from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1111c/-

LFCtreatmentdescriptionclass of inhibitor

0.035

Amikacinug/mL Amikacintranslation

0.166

Cap5-10ug/mL Capreomycintranslation

-0.435

Rox10-50 ug/mL Roxithromycintranslation

0.598

SM2-5 ug/mL Streptomycintranslation

0.880

Tet5-10 ug/mL Tetracyclinetranslation

-0.444

Rif0.2-5ug/mL Rifampicintranscription

0.881

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.634

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.612

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.628

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.400

Clofazimine10-13 ug/mL Clofaziminerespiration

0.246

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.446

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.429

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.728

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.009

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.779

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.745

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.994

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.199

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.605

KCN5-20 ug/mL Potassium cyaniderespiration

-0.412

NaN30.2-2 mM Sodium aziderespiration

-0.313

Nigericin50 uM Nigericinrespiration

-1.057

TRC10-150 ug/mL Triclosanrespiration

-2.008

TRZ10-25 ug/mL Thioridazinerespiration

-1.430

Valinomycin0.5-10 uM Valinomycinrespiration

1.060

ZnSO42 mM ZnSO4respiration

-0.461

menadione6-10 ug/mL Menadionerespiration

-0.120

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.947

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.195

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.994

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.197

NRP_1Non-replicating persistence stage 1dosRassociated

0.773

Amp0.2mg/mL AmpicillincellWall

1.014

Cephalexin20-100 ug/mL CephalexincellWall

1.026

Cerulenin0.32-5 ug/mL CerulenincellWall

0.694

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.553

EMB10-20 ug/mL EthambutolcellWall

0.822

Eta12-40 ug/mL EthionamidecellWall

0.956

INH0.2-0.4 ug/mL IsoniazidcellWall

0.594

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.197

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.767

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.648

BZA0.12 mg/mL BenzamidearomaticAmides

-0.170

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.220

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.301

H2O24 mM hydrogen peroxideDNAdamaging

0.745

Levo10 ug/mL LevofloxacinDNAdamaging

0.845

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.649

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.731

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.497

UVUV-irradiationDNAdamaging

-1.296

ARP41-4 ug/mL Antitubercular compound ARP4?

0.677

Antimycin12.5-50 ug/mL Antimycin A?

0.773

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.752

PA_110-50 ug/mL Antitubercular compound PA-1?

0.755

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.207

PA8240.2-2 ug/mL PA-824?

-0.572

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.225

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.438

Verapamil50 uM Verapamil?

0.629

mercaptoethanol2 mM 2-Mercaptoethanol?

0.618

methoxatin10-20 ug/mL Methoxatin?